N2-Acetylornithine
|
Basic information |
| Metabolite name | N2-Acetylornithine |
 | HMDB0003357 |
 |
C00437 |
 |
439232 |
| Synonyms | N-Acetylornithine; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | N2-Acetylornithine |
| HMDB0003357 |
|
C00437 |
|
439232 |
| Synonyms | N-Acetylornithine; |
| No. of studies | 6 |
|
Relationship between N2-Acetylornithine and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1072 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Prefrontal cortex | Cynomolgus monkey | Up |
| Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, discovery cohort | Plasma | Human | Up |
| Study M715 | Type1 | MDD group vs. control group | Faece | Human | Down |
| Study M749 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M779 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M779 | Type2 | depression group, post vs. before treatment | Plasma | Human | Up |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Down |